FDA Inspection 1224419 - CellSure, L3C - December 08, 2023

Record Details

This FDA Inspection record concerns CellSure, L3C, with an inspection on December 8, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: CellSure, L3C
Inspection Date: December 8, 2023
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 2a9579b3-ecc6-4ac3-968f-41b2b44409af

Violation Codes6

21 CFR 1271.75(a)(1)21 CFR 1271.90(c)21 CFR 211.14221 CFR 211.15021 CFR 211.166(a)21 CFR 211.22(c)

Full citation text and observation details available on the Dashboard.